Huizhen He
1PUBLICATIONS
0CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (1)
Sort by Publication Date:
|Sep 11, 2025
Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma.Shuai Tan, Huizhen He, Jing Ni
Pageof 1
